Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016271851> ?p ?o ?g. }
- W2016271851 endingPage "4188" @default.
- W2016271851 startingPage "4176" @default.
- W2016271851 abstract "The identification of essential genetic elements in pathways governing the maintenance of fully established tumors is critical to the development of effective antioncologic agents. Previous studies revealed an essential role for H-RASV12G in melanoma maintenance in an inducible transgenic model. Here, we sought to define the molecular basis for RAS-dependent tumor maintenance through determination of the H-RASV12G-directed transcriptional program and subsequent functional validation of potential signaling surrogates. The extinction of H-RASV12G expression in established tumors was associated with alterations in the expression of proliferative, antiapoptotic, and angiogenic genes, a profile consistent with the observed phenotype of tumor cell proliferative arrest and death and endothelial cell apoptosis during tumor regression. In particular, these melanomas displayed a prominent RAS-dependent regulation of the epidermal growth factor (EGF) family, leading to establishment of an EGF receptor signaling loop. Genetic complementation and interference studies demonstrated that this signaling loop is essential to H-RASV12G-directed tumorigenesis. Thus, this inducible tumor model system permits the identification and validation of alternative points of therapeutic intervention without neutralization of the primary genetic lesion." @default.
- W2016271851 created "2016-06-24" @default.
- W2016271851 creator A5010863408 @default.
- W2016271851 creator A5015401462 @default.
- W2016271851 creator A5023275495 @default.
- W2016271851 creator A5057851288 @default.
- W2016271851 creator A5064406116 @default.
- W2016271851 creator A5076813249 @default.
- W2016271851 creator A5089559870 @default.
- W2016271851 creator A5089948252 @default.
- W2016271851 date "2005-05-01" @default.
- W2016271851 modified "2023-09-28" @default.
- W2016271851 title "Role of Epidermal Growth Factor Receptor Signaling in RAS-Driven Melanoma" @default.
- W2016271851 cites W1483388049 @default.
- W2016271851 cites W1506719196 @default.
- W2016271851 cites W1514456064 @default.
- W2016271851 cites W1539571840 @default.
- W2016271851 cites W1552225369 @default.
- W2016271851 cites W1586093731 @default.
- W2016271851 cites W1756183899 @default.
- W2016271851 cites W1798150156 @default.
- W2016271851 cites W1939830750 @default.
- W2016271851 cites W1954903971 @default.
- W2016271851 cites W1965157624 @default.
- W2016271851 cites W1966453709 @default.
- W2016271851 cites W1971512164 @default.
- W2016271851 cites W1978368163 @default.
- W2016271851 cites W1978743664 @default.
- W2016271851 cites W1985275612 @default.
- W2016271851 cites W1991760443 @default.
- W2016271851 cites W1999441881 @default.
- W2016271851 cites W2001483337 @default.
- W2016271851 cites W2003223749 @default.
- W2016271851 cites W2007179773 @default.
- W2016271851 cites W2009283506 @default.
- W2016271851 cites W2014624348 @default.
- W2016271851 cites W2017235640 @default.
- W2016271851 cites W2023325850 @default.
- W2016271851 cites W2028752124 @default.
- W2016271851 cites W2034459612 @default.
- W2016271851 cites W2039627657 @default.
- W2016271851 cites W2050168543 @default.
- W2016271851 cites W2051894369 @default.
- W2016271851 cites W2054318886 @default.
- W2016271851 cites W2056269792 @default.
- W2016271851 cites W2056573428 @default.
- W2016271851 cites W2059433877 @default.
- W2016271851 cites W2071220987 @default.
- W2016271851 cites W2076506898 @default.
- W2016271851 cites W2082044596 @default.
- W2016271851 cites W2087220149 @default.
- W2016271851 cites W2087404852 @default.
- W2016271851 cites W2094404156 @default.
- W2016271851 cites W2100409527 @default.
- W2016271851 cites W2105006863 @default.
- W2016271851 cites W2106537213 @default.
- W2016271851 cites W2108491944 @default.
- W2016271851 cites W2110128078 @default.
- W2016271851 cites W2110719738 @default.
- W2016271851 cites W2112572166 @default.
- W2016271851 cites W2117669008 @default.
- W2016271851 cites W2119465831 @default.
- W2016271851 cites W2121627701 @default.
- W2016271851 cites W2123206362 @default.
- W2016271851 cites W2125547572 @default.
- W2016271851 cites W2132787700 @default.
- W2016271851 cites W2141100404 @default.
- W2016271851 cites W2147822352 @default.
- W2016271851 cites W2163188200 @default.
- W2016271851 cites W2169401275 @default.
- W2016271851 cites W2169547107 @default.
- W2016271851 cites W2183635321 @default.
- W2016271851 cites W2276369696 @default.
- W2016271851 cites W2314934187 @default.
- W2016271851 cites W2413938837 @default.
- W2016271851 cites W2467291894 @default.
- W2016271851 cites W4242546443 @default.
- W2016271851 cites W4313305984 @default.
- W2016271851 cites W4361851957 @default.
- W2016271851 doi "https://doi.org/10.1128/mcb.25.10.4176-4188.2005" @default.
- W2016271851 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1087708" @default.
- W2016271851 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15870287" @default.
- W2016271851 hasPublicationYear "2005" @default.
- W2016271851 type Work @default.
- W2016271851 sameAs 2016271851 @default.
- W2016271851 citedByCount "62" @default.
- W2016271851 countsByYear W20162718512012 @default.
- W2016271851 countsByYear W20162718512013 @default.
- W2016271851 countsByYear W20162718512014 @default.
- W2016271851 countsByYear W20162718512015 @default.
- W2016271851 countsByYear W20162718512016 @default.
- W2016271851 countsByYear W20162718512017 @default.
- W2016271851 countsByYear W20162718512018 @default.
- W2016271851 countsByYear W20162718512019 @default.
- W2016271851 countsByYear W20162718512021 @default.
- W2016271851 countsByYear W20162718512022 @default.
- W2016271851 countsByYear W20162718512023 @default.
- W2016271851 crossrefType "journal-article" @default.